As reported to coloplast though not verified, patient's legal representative stated according to the available information the patient's legal representative stated vaginal odor, uti symptoms.Aris was implanted on (b)(6) 2007 and remains implanted.Additional information was received stating the patient suffered serious bodily injuries, including but not limited to foreign body reaction, urinary problems, dyspareunia, pelvic pain, vaginal pain, groin pain, leg pain, urinary tract infections, and other injuries.This event was initial reported on (b)(6) 2016 on alternative summary reporting - exemption number (b)(4).
|
Additional information received on 8/8/2023 as follows: patient experienced voiding dysfunction, vaginal extrusion of mesh, and bothersome anterior vaginal prolapse.Vaginal exploration with partial removal of tot, vaginal reconstruction under general anesthesia was performed.
|
The lot number was reviewed for complaint trend, nonconforming report and capa.Devices met specification prior to release.No trends were noted for complaints and there were no nonconforming reports or capas that were confirmed to be associated.This complaint was investigated to the extent information was provided to coloplast.Due to the legal nature of this complaint and the device not being returned for evaluation a thorough investigation could not be executed.Should additional information become available, this file will be re-evaluated and updated according to current procedures.Complaints of this nature are monitored and captured within the product risk documentation.No further action or corrective action is required at this time.
|